A Mendelian Randomization Study of Infant Length and Type 2 Diabetes Mellitus Risk.
CONCLUSIONS: We validated that the shorter IL contributes no additional risk to T2DM. The sensitivity analysis and the MR-Egger regression analysis also provided adequate evidence the above result was not due to any heterogeneity or pleiotropic effect of IVs.
PMID: 31553296 [PubMed - as supplied by publisher]
Source: Current Gene Therapy - Category: Genetics & Stem Cells Authors: Zhuang H, Zhang Y, Yang S, Cheng L, Liu SL Tags: Curr Gene Ther Source Type: research
More News: Diabetes | Diabetes Mellitus | Diabetes Type 2 | Endocrinology | Gene Therapy | Genetics | Men | Study